2-(Bromomethyl)-3,5,6-trimethylpyrazine

Catalog No.: 
ACKAMC489
CAS No.: 
79074-45-6
Molecular Formula: 
C8H11BrN2
Molecular Weight: 
215.09
2-(Bromomethyl)-3,5,6-trimethylpyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$134.00InquiryInquiry
250mg95%$232.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Bromomethyl)-3,5,6-trimethylpyrazine
IUPAC Name2-(bromomethyl)-3,5,6-trimethylpyrazine
Molecular FormulaC8H11BrN2
Molecular Weight215.09
SMILESCC1=NC(C)=C(CBr)N=C1C
InChI KeyHOPVUIZLMIEGMJ-UHFFFAOYSA-N
Synonym2-(BROMOMETHYL)-3,5,6-TRIMETHYLPYRAZINE;broMoMethyl-3,5,6-triMethylpyrazine;Pyrazine, 2-(bromomethyl)-3,5,6-trimethyl-
CAS No.79074-45-6
PubChem CID13584992

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACKAMC489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFMGK015 route compound structure diagram
    ACFMGK0151124-11-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKAMC489 route product structure diagram
    ACKAMC48979074-45-6
Inquiry

2. ACKAMC489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBQJ043 route compound structure diagram
    ACLBQJ04375907-74-3In Stock
  4. Then
  5. ACKAMC489 route product structure diagram
    ACKAMC48979074-45-6
Inquiry

3. ACKAMC489 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMFKN371 route compound structure diagram
    ACMFKN371186534-02-1In Stock
  4. Then
  5. ACKAMC489 route product structure diagram
    ACKAMC48979074-45-6
Inquiry

Comments (0)